Market Place
Sourcing Support
ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210
19 Jul 2023 //
BUSINESSWIRE
Armgo bags $35M for phase 2 heart rhythm study
21 Dec 2021 //
FIERCEBIOTECH
ARMGO raises $35 million to progress clinical studies of lead molecule ARM210
20 Dec 2021 //
GLOBENEWSWIRE
ARMGO® Pharma Inc. Announces Clinical Trial of ARM210/S48168
17 Dec 2019 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.